#1 Clinical Trials Search in Europe

Ivermectin

Ivermectin, a well-known antiparasitic drug, has been the subject of numerous clinical trials exploring its potential uses beyond its traditional applications. This article examines various studies investigating ivermectin’s efficacy in treating conditions ranging from COVID-19 to chronic strongyloidiasis, as well as its use in different formulations and dosages. We’ll look at how researchers are evaluating ivermectin’s safety, effectiveness, and potential new applications in medical treatment.

Table of Contents

What is Ivermectin?

Ivermectin is a medication that has been used for many years to treat various parasitic infections in humans and animals. It belongs to a group of drugs called avermectins, which are derived from bacteria found in soil[1]. Ivermectin is known by several brand names, including Stromectol, Soolantra, and Revemact[2][3].

This medication has been included in the World Health Organization’s (WHO) Essential Medicines List since 1980, highlighting its importance in global healthcare[1]. Ivermectin is widely used and millions of doses are administered annually through mass drug distribution programs organized by the WHO[1].

Uses of Ivermectin

Ivermectin is primarily used to treat parasitic infections. Some of the conditions it can help with include:

  • Onchocerciasis (river blindness): A parasitic infection that can cause eye and skin problems[4].
  • Strongyloidiasis: An infection caused by roundworms that can live in the intestines[5].
  • Lymphatic filariasis: A parasitic disease that can cause severe swelling in the limbs and genitals[1].
  • Scabies: A skin condition caused by tiny mites[1].
  • Rosacea: A skin condition that causes redness and visible blood vessels in the face[6].

Ivermectin works by paralyzing and killing the parasites responsible for these conditions. It’s particularly effective against parasites that live in or on the body[1].

Ivermectin and COVID-19

During the COVID-19 pandemic, there has been interest in using ivermectin as a potential treatment. Some studies have looked at whether ivermectin could help reduce the replication (multiplication) of the SARS-CoV-2 virus, which causes COVID-19[7].

However, it’s important to note that as of the time these trials were conducted, the effectiveness of ivermectin for treating COVID-19 was not proven. More research was needed to determine if it could be a useful treatment option. Patients should always follow the advice of their healthcare providers regarding COVID-19 treatment[7].

Administration and Dosage

Ivermectin can be administered in different ways, depending on the condition being treated:

  • Oral tablets: These are the most common form for treating internal parasitic infections. The dosage is usually based on body weight[2].
  • Topical cream: For skin conditions like rosacea, ivermectin may be applied directly to the skin[6].
  • Oral suspension: A liquid form of ivermectin is being developed, which may be easier for children to take[3].

The exact dosage and duration of treatment can vary widely depending on the condition being treated. For example, some parasitic infections may be treated with a single dose, while others might require multiple doses over several days or weeks[5]. Always follow your doctor’s instructions regarding dosage and duration of treatment.

Side Effects and Safety

Ivermectin is generally considered safe when used as prescribed. However, like all medications, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Dizziness
  • Muscle pain
  • Nausea or diarrhea
  • Mild skin rash

In rare cases, more serious side effects can occur. If you experience any unusual or severe symptoms after taking ivermectin, contact your healthcare provider immediately[1].

It’s important to note that ivermectin should only be used under the guidance of a healthcare professional. Self-medication, especially with forms of ivermectin intended for animal use, can be dangerous and should be avoided[7].

Ongoing Research

Scientists continue to study ivermectin to better understand its effects and potential uses. Some areas of ongoing research include:

  • Comparing the effectiveness of ivermectin to other medications for treating parasitic infections[5].
  • Investigating new formulations of ivermectin, such as oral suspensions, which may be easier for some patients to take[3].
  • Studying the drug’s effects on various parasites and how quickly it can clear them from the body[4].
  • Exploring potential new uses for ivermectin in treating other conditions[6].

As research continues, our understanding of ivermectin and its potential uses may expand. Always consult with your healthcare provider for the most up-to-date information about this medication and whether it’s appropriate for your specific health needs.

Aspect Details
Conditions Studied COVID-19, onchocerciasis, chronic strongyloidiasis, rosacea
Administration Forms Oral tablets, nasal sprays, topical creams
Primary Outcomes Parasite clearance, COVID-19 symptom reduction, mortality rates, pharmacokinetic parameters
Comparison Treatments Albendazole, standard of care
Safety Profile Generally considered high, but monitored in trials
Notable Studies Bioequivalence studies, COVID-19 treatment and prevention, parasitic infection treatment

FAQ

  • What conditions are being studied using ivermectin in clinical trials? Clinical trials are exploring ivermectin's use in various conditions, including COVID-19, onchocerciasis (river blindness), chronic strongyloidiasis (a parasitic infection), and rosacea. Some studies are also examining its potential as a preventive measure against SARS-CoV-2 infection in healthcare workers.
  • How is ivermectin being administered in these trials? Ivermectin is being tested in various forms, including oral tablets, nasal sprays, and topical creams. The dosage and frequency of administration vary depending on the condition being treated and the specific trial design.
  • What are some of the primary outcomes researchers are measuring in ivermectin trials? Researchers are measuring various outcomes, including clearance of parasites from the body, reduction in COVID-19 symptoms, mortality rates, length of hospital stay, and pharmacokinetic parameters such as maximum plasma concentration (Cmax) and area under the plasma concentration curve (AUC).
  • Are there any notable side effects or safety concerns with ivermectin use in these trials? While the trials mentioned don't specifically focus on side effects, ivermectin is generally considered to have a high safety profile. However, as with any medication, potential side effects and safety concerns are always monitored closely in clinical trials.
  • How do these trials compare ivermectin to other treatments? Some trials compare ivermectin to other treatments or standard of care. For example, one study compares ivermectin to albendazole for treating chronic strongyloidiasis. In COVID-19 studies, ivermectin is often compared to standard care or used as an additional treatment alongside standard care.

Ongoing Clinical Trials on Ivermectin

  • Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on the Effectiveness and Safety of Ivermectin Cream Compared to a Drug Combination for Patients with Papulopustular Rosacea

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on Treating Scabies with Permethrin and Ivermectin for Patients with Scabies

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany

  • Study on Ivermectin for Treating Strongyloidiasis in Adults with Normal Immune Function

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

    Not recruiting

    1 1
    Investigated drugs:
    Czechia France Italy Lithuania The Netherlands Poland +2

Glossary

  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration, showing comparable bioavailability and producing the same therapeutic effect.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Onchocerciasis: Also known as river blindness, it's a parasitic disease caused by the worm Onchocerca volvulus, transmitted through the bite of infected blackflies.
  • Strongyloidiasis: A parasitic disease caused by Strongyloides stercoralis, a type of roundworm that can infect humans through contaminated soil.
  • RT-PCR: Reverse Transcription Polymerase Chain Reaction, a laboratory technique used to detect specific genetic material, such as the RNA of the SARS-CoV-2 virus.
  • Microfilaria (Mf): The microscopic larval stage of certain parasitic worms, such as those that cause onchocerciasis, found in the blood or tissues of infected hosts.
  • Cmax: The maximum concentration of a drug in the blood plasma after administration, used to evaluate the drug's absorption and effectiveness.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, calculated from a graph of drug concentration in blood plasma against time.

References

  1. https://clinicaltrials.gov/study/NCT04381884
  2. https://clinicaltrials.gov/study/NCT04854460
  3. https://clinicaltrials.gov/study/NCT03717558
  4. https://clinicaltrials.gov/study/NCT03517462
  5. https://clinicaltrials.gov/study/NCT00765024
  6. https://clinicaltrials.gov/study/NCT04106726
  7. https://clinicaltrials.gov/study/NCT04530474